Advances in research on miR-181 family members and malignant tumors

Tumor

Volumn 32, Issue 10, 2012, Pages 837-841

  Zhu, Yao Kui ^a   Cheng, Ni ^a   Zhang, Lei ^a   Cen, Ying Zhou ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Diagnosis; Genes regulator; Hsa miR 181; Micro RNAs; Neoplasms; Prognosis

Indexed keywords

K RAS PROTEIN; MICRORNA; MICRORNA 181; OSTEOPONTIN; PROTEIN BCL 2; PROTEIN TYROSINE PHOSPHATASE SHP 2; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; DISEASE ASSOCIATION; ESOPHAGUS CANCER; FAMILY; GLIOMA; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MOUTH SQUAMOUS CELL CARCINOMA; ONCOGENE; REVIEW; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

EID: 84869201282     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2012.10.014     Document Type: Review

References (29)

1. LEE R C, FEINBAUM R L, AMBROS V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.
2. LIMA R T, BUSACCA S, ALMEIDA G M, et al . MicroRNA regulation of core apoptosis pathways in cancer[J]. Eur J Cancer, 2011, 47(2):163-174.
3. RUVKUN G. Molecular biology. Glimpses of a tiny RNA world[J]. Science, 2001, 294(5543):797-799.
4. NAGUIBNEVA I, AMEYAR-ZAZOUA M, POLESSKAYA A, et al . The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation[J]. Nat Cell Biol, 2006, 8(3):278-284.
5. CICHOCKI F, FELICES M, MCCULLAR V, et al . Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling[J]. J Immunol, 2011, 187(12):6171-6175.
6. LI Y G, ZHANG P P, JIAO K L, et al . Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with myocardial infarction[J]. Microvasc Res, 2009, 78(3):393-404.
7. KUMAR S, NAQVI RA, KHANNA N, et al . Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b crosstalk and miR-181a towards T cell hyporesponsiveness in leprosy[J]. Mol Immunol, 2011, 48(9-10):1178-1190.
8. OUYANG Y B, LU Y, YUE S, et al . miR-181 regulates GRP78 and influences outcome from cerebral ischemia in vitro and in vivo [J]. Neurobiol Dis, 2012, 45(1):555-563.
9. BHATTACHARYA S D, GARRISON J, GUO H, et al . Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines[J]. Surgery, 2010, 148(2):291-297.
10. SUN B S, DONG Q Z, YE Q H, et al . Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma[J]. Hepatology, 2008, 48(6):1834-1842.
11. JI J, YAMASHITA T, BUDHU A,, et al . Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells[J]. Hepatology, 2009, 50(2):472-480.
12. WANG B, HSU S H, MAJUMDER S, et al . TGFbetamediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3[J]. Oncogence, 2010, 29(12):1787-1797.
13. CHEN L, YANG Q, KONG W Q, et al . MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas[J]. IUBMB Life, 2012, 64(7):628-635.
14. HASHIMOTO Y, AKIYAMA Y, OTSUBO T, et al. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis[J]. Carcinogenesis, 2010, 31(5):777-784.
15. JIANG J, ZHENG X, XU X, et al . Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin[J]. PLoS One, 2011, 6(8):e23271.
16. SHIN K H, BAE S D, HONG H S, et al . miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras[J]. Biochem Biophys Res Commun, 2011, 404(4):896-902.
17. YANG C C, HUNG P S, WANG P W, et al . miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma[J]. J Oral Pathol Med, 2011, 40(5):397-404.
18. SHI L, CHENG Z, ZHENG J, et al . hsa-mir-181a and hsamir-181b function as tumor suppressors in human glioma cells[J]. Brain Res, 2008, 1236:185-193.
19. WANG X F, SHI Z M, WANG X R, et al . MiR-181d acts as a tumor suppressor in glioma by targeting k-ras and Bcl-2[J]. J Cancer Res Clin, 2012, 138(4):573-584.
20. PING L, XIAOMING L, YINGYI W, et al . MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells[J]. J Biomed Res, 2010, 24(6):436-443.
21. RADEK L, JIRI S, SIMONA H, et al . MiR-195, miR-196b, miR-181c, miR-21 expression levels and O -6-me t h y l g u a n i n e -DNA me t h y l t r a n s f e r a s e methylation status are associated with clinical outcome in glioblastoma patients[J]. Cancer Sci, 2011, 102(12):1286-1290.
22. ZHI F, CHEN X, WANG S, et al . The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma[J]. Eur J Cancer, 2010, 46(9):1640-1649.
23. CONTI A, AGUENNOUZ M, TORRE D, et al . miR-21 and 221 upregulation and miR-181b downregulation in human grade II -III astrocytic tumors[J] J Neurooncol, 2009, 93(3):325-332.
24. GAO W, YU Y, CAO H, et al . Deregulated expression of miR-21, miR-143 and miR-181a in non-small cell lung cancer is related to clinicopathologic characteristics or patient prognosis[J]. Biomed Pharmacother, 2010, 64(6):399-408.
25. ZHU W, SHAN X, WANG T, et al . miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines[J]. Int J Cancer, 2010, 127(11):2520-2529.
26. PEKARSKY Y, SANTANAM U, CIMMINO A, et al . Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181[J]. Cancer Res, 2006, 66(24):11590-11593.
27. CHEN H, CHEN Q, FANG M, et al . MicroRNA-181b targets MLK2 in HL-60 cells[J]. Sci China Life Sci, 2010, 53(1):101-106.
28. BAI H, CAO Z, DENG C, et al . MiR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis[J]. J Cancer Res Clin Oncol, 2012, 138(4):595-602.
29. WANG Y, YU Y, TSUYADA A, et al . Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM[J]. Oncogence, 2011, 30(12):1470-1480.